Literature DB >> 4611209

Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature.

F Rosner, H Grünwald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4611209     DOI: 10.1016/0002-9343(74)90171-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  23 in total

1.  Remission of acute myelogenous leukemia complicating Waldenström macroglobulinemia.

Authors:  M K Effron; J Rosenbaum; P L Greenberg
Journal:  West J Med       Date:  1978-10

2.  Letter: Maintenance therapy in myeloma: risk versus benefit.

Authors:  S M Sieber; R H Adamson
Journal:  Br Med J       Date:  1975-06-07

3.  Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture.

Authors:  J Buxbaum
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

4.  Immune function of successfully treated lymphoma patients.

Authors:  G W King; B Yanes; P E Hurtubise; S P Balcerzak; A F LoBuglio
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

5.  Plasma cell leukemia following treatment with radiotherapy and melphalan.

Authors:  N A Buskard; D A Boyes; L Grossman
Journal:  Can Med Assoc J       Date:  1977-10-08       Impact factor: 8.262

6.  Second malignant neoplasms in Hodgkin's disease.

Authors:  E P Getaz
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Acute myelomonocytic leukemia following splenectomy in a patient with long-standing Hodgkin disease.

Authors:  B E Rosenbloom; E J Klein; J M Uszler; R Ellis; J B Block; K R Tanaka
Journal:  West J Med       Date:  1978-10

Review 8.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

9.  Development and operation of a pharmacy-based intravenous cytotoxic reconstitution service.

Authors:  M Anderson; D Brassington; J Bolger
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-01

10.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.